Skip to main content
. 2023 Mar 3;18(10):2127–2133. doi: 10.4103/1673-5374.369096

Figure 2.

Figure 2

Targets for gene therapy in Alzheimer’s disease.

ApoE4: Apolipoprotein E4; APP: amyloid protein precursor; BACE1: β-site amyloid precursor protein cleaving enzyme 1; BDNF: brain-derived neurotrophic factor; GSK3β: glycogen beta kinase-3-beta; NGF: nerve growth factor; TREM2: triggering receptor expressed on myeloid cells 2; VEGF: vascular endothelial growth factor. Created with BioRender.com.